Skip to main content

Table 4 Medical treatment during index hospitalization in NSTEMI patients.

From: The effect of tobacco smoking and treatment strategy on the one-year mortality of patients with acute non-ST-segment elevation myocardial infarction

 

Non-smokers

Smokers

 

CS

(n = 127)

IS

(n = 151)

p-value

CS

(n = 54)

IS

(n = 49)

p-value

Aspirin

103 (81%)

124 (82%)

0.95

48 (90%)

45 (92%)

0.86

Clopidogrel

92 (72%)

118 (78%)

0.34

46 (85%)

46 (94%)

0.27

Beta-blocker

110 (87%)

123 (82%)

0.32

46 (85%)

42 (86%)

1.00

ACE-I/ARB

53 (42%)

77 (51%)

0.16

22 (41%)

19 (39%)

1.00

Statins

74 (58%)

106 (70%)

0.051

40 (74%)

44 (90%)

0.072

  1. Categorical data presented as n (%).
  2. ACE-I, angiotensin converting enzyme inhibitor; ARB, angiotensin-II receptor blocker; CS, conservative strategy cohort; IS, invasive strategy cohort; NSTEMI, non-ST-segment elevation myocardial infarction.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us